Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying C Henderson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 27, 2014
Development and characterization of six new human papillary thyroid carcinoma cell linesYing C Henderson, Soon-Hyun Ahn, Junsun Ryu, et al.
Frontiers in Immunology|June 13, 2024
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapyNaimah Turner, Sarah Hamidi, Rim Ouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine modelMaria K Gule, Yunyun Chen, Daisuke Sano, et al.
Nature Biotechnology|January 19, 2021
Delineating copy number and clonal substructure in human tumors from single-cell transcriptomesRuli Gao, Shanshan Bai, Ying C Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sitesMei Zhao, Daisuke Sano, Curtis R Pickering, et al.
British Journal of Cancer|March 20, 2021
Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancerYunyun Chen, Anastasios Maniakas, Lin Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2019
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical StudiesIñigo Landa, Nikita Pozdeyev, Christopher Korch, et al.
The American Journal of Pathology|February 2, 2011
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesMitchell J Frederick, Amy J VanMeter, Mayur A Gadhikar, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2021
Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic DiversityAnastasios Maniakas, Ying C Henderson, Hu Hei, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|November 27, 2014
Development and characterization of six new human papillary thyroid carcinoma cell linesYing C Henderson, Soon-Hyun Ahn, Junsun Ryu, et al.
Frontiers in Immunology|June 13, 2024
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapyNaimah Turner, Sarah Hamidi, Rim Ouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine modelMaria K Gule, Yunyun Chen, Daisuke Sano, et al.
Nature Biotechnology|January 19, 2021
Delineating copy number and clonal substructure in human tumors from single-cell transcriptomesRuli Gao, Shanshan Bai, Ying C Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sitesMei Zhao, Daisuke Sano, Curtis R Pickering, et al.
British Journal of Cancer|March 20, 2021
Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancerYunyun Chen, Anastasios Maniakas, Lin Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2019
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical StudiesIñigo Landa, Nikita Pozdeyev, Christopher Korch, et al.
The American Journal of Pathology|February 2, 2011
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesMitchell J Frederick, Amy J VanMeter, Mayur A Gadhikar, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2021
Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic DiversityAnastasios Maniakas, Ying C Henderson, Hu Hei, et al.
Pageof 3